Home › Adenocarcinoma esofageo › Pennsylvania › Philadelphia
Studi clinici su Adenocarcinoma esofageo a Philadelphia, PA
8 studi su Adenocarcinoma esofageo cercano partecipanti presso sedi a Philadelphia e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
In reclutamentoFase 2/3
- Thomas Jefferson University Hospital, Philadelphia
- Jefferson Torresdale Hospital, Philadelphia
- Asplundh Cancer Pavilion, Willow Grove · a 13 mi di distanza
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
In reclutamentoFase 3
- Thomas Jefferson University Hospital, Philadelphia
- Einstein Medical Center Philadelphia, Philadelphia
- Asplundh Cancer Pavilion, Willow Grove · a 13 mi di distanza
- e altri 2
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
In reclutamentoFase 2/3
- Alliance Cancer Specialists, PC, Wynnewood · a 7 mi di distanza
- Alliance Cancer Specialists, PC, Media · a 12 mi di distanza
- Alliance Cancer Specialists, PC, Horsham · a 16 mi di distanza
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
In reclutamentoFase 1
- Sidney Kimmel Comprehensive Cancer Center Thomas Jefferson University, Philadelphia
Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
In reclutamento
- University of Pennsylania, Perelman School of Medicine, Philadelphia
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
In reclutamentoFase 3
- Research Site, Philadelphia
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
In reclutamentoFase 1
- Normunity Investigational Site, Philadelphia
- Normunity Investigational Site, Philadelphia
Study of Suratadenoturev (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma
In reclutamentoFase 2
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Studi su Adenocarcinoma esofageo in altre città
- New York City, NY18 studi
- Boston, MA13 studi
- Houston, TX12 studi
- Arlington, VA11 studi
- Nashville, TN11 studi
- Durham, NC10 studi
- Baldwin Park, CA9 studi
- St. Louis, MO9 studi
- Rochester, MN9 studi
- Jacksonville, FL9 studi
- Queens, NY9 studi
- Los Angeles, CA9 studi
Altri studi a Philadelphia
- Cancro (tutti i tipi)59 studi
- Cancro al seno56 studi
- Cancro del polmone non a piccole cellule51 studi
- Cancro metastatico46 studi
- Cancro alla prostata44 studi
- Cancro colorettale44 studi
- Cancro ovarico44 studi
- Cancro ai polmoni36 studi
- Leucemia mieloide acuta34 studi
- Insufficienza cardiaca31 studi
- Cancro dell'endometrio28 studi
- Depressione26 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.